中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

醒脑静联合盐酸纳洛酮抢救脑出血伴昏迷患者的临床效果

强忙春,党亚东

(西安航天总医院急诊科,陕西 西安,710100)

浏览次数:80次 下载次数:339次

摘要:

目的 探讨醒脑静联合盐酸纳洛酮抢救脑出血伴昏迷患者的临床效果。方法 选取我院2015年1月至2016年6月收治的脑出血伴昏迷患者216例,将其随机分为研究组和对照组,各108例。对照组患者给予基础治疗加盐酸纳洛酮注射液治疗, 研究组患者在此基础上加用醒脑静注射液治疗,观察两组患者的临床疗效及治疗前后的脑血肿量及昏迷时间。结果 研究组患者临床治疗总有效率为96.30%(104/108),高于对照组的86.11%(93/108)(P<0.05);治疗前,两组患者脑血肿量差异不具有统计学意义(P>0.05),治疗后,两组患者脑血肿量明显下降,研究组患者下降得更为显著(P<0.05);研究组患者的昏迷时间 为(7.01±2.01)d,短于对照组的(10.34±1.89)d(P<0.05)。结论 醒脑静联合盐酸纳洛酮治疗脑出血伴昏迷患者的临床效果显 著,可推广使用。

关键词:脑出血;昏迷;醒脑静;盐酸纳洛酮

中图分类号:R743.34文献标志码:A文章编号:2096-1413(2016)27-0021-02

    The clinical effect of Xingnaojing combined with naloxone hydrochloride in the treatment of cerebral hemorrhage with coma patients
    QIANG Mang-chun, DANG Ya-dong
    (Department of Emergency, Xi`an Aerospace General Hospital, Xi`an 710100, China)

    ABSTRACT: Objective To investigate the clinical effect of Xi ngnaojing combined with naloxone hydrochloride in the treatment of cerebral hemorrhage with coma patients. Methods Two hundred and sixteen cases of cerebral hemorrhage with coma patients admitted in our hospital from January 2015 to June 2016 were selected and randomly divided into study group and control group, with 108 cases in each group. The control group was given basic treatment combined with naloxone hydrochloride injection, while the study group received Xingnaojing injection on the basis of the control group, the clinical efficacy, cerebral hematoma volume before and after treatment and coma time were observed and compared between the two groups. Results The total effective rate of the study group was 96.30% (104/108), which was significantly higher than 86.11% (93/108) of the control group (P<0.05). Before treatment, the difference in cerebral hematoma volume between the two groups had no statistical significance (P>0.05); after treatment, the cerebral hematoma volume of the two groups both decreased significantly, but the study group decreased more significantly (P<0.05); The coma time of the study group was (7.01±2.01) d, which was significantly shorter than (10.34±1.89) d of the control group (P<0.05). Conclusion The clinical effect of Xingnaojing combined with naloxone hydrochloride in the treatment of cerebral hemorrhage with coma is positive, which can be widely used.
    KEYWORDS: cerebral hemorrhage; coma; Xingnaojing; naloxone hydrochloride

    参考文献:
    [1] 张芳,曹健民.醒脑静联合盐酸纳洛酮治疗脑出血后昏迷患者的疗效观察[J].实用预防医学,2011,18(6):1090-1092.
    [2] 高正主.醒脑静联合盐酸纳洛酮治疗脑出血后昏迷患者的临床效果分析[J].贵阳中医学院学报,2013,35(2):61-63.
    [3] 叶刚.醒脑静联合盐酸纳洛酮治疗脑出血后昏迷患者的疗效观察[J].海峡药学,2013,25(9):1090-1092.
    [4] 冷晓波,尹玉香.醒脑静联合盐酸纳洛酮治疗脑出血后昏迷的临床效果观察[J].中国实用医药,2015,10(36):112-113.
    [5] 丁淑侠.联合应用醒脑静和盐酸纳洛酮治疗脑出血后昏迷的临床疗效观察[J].中国医药指南,2015,13(21):80.
    [6] 朱婉茸.醒脑静联合盐酸纳洛酮治疗脑出血后昏迷的临床疗效分析[J].中外医疗,2015,32(5):109-110.
    [7] 巩同玉,耿涛.评价应用醒脑静与盐酸纳洛酮联合治疗脑出血后昏迷患者的效果[J].中国医药指南,2016,14(8):190-191.

上一篇开放式胃癌根治术治疗83例胃癌患者的临床疗效分析

下一篇螺内酯治疗充血性心力衰竭的临床观察